Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Infant Mortality | 6 | 2024 | 757 | 1.880 |
Why?
|
India | 30 | 2024 | 2325 | 1.770 |
Why?
|
Postnatal Care | 3 | 2024 | 273 | 1.460 |
Why?
|
Tropomyosin | 5 | 2009 | 106 | 1.350 |
Why?
|
Prenatal Care | 5 | 2024 | 1159 | 1.340 |
Why?
|
Nanotubes | 2 | 2023 | 83 | 1.130 |
Why?
|
Sterilization, Reproductive | 2 | 2018 | 24 | 1.050 |
Why?
|
Marriage | 4 | 2018 | 352 | 0.860 |
Why?
|
Actins | 5 | 2009 | 2059 | 0.810 |
Why?
|
Sex Ratio | 1 | 2021 | 107 | 0.710 |
Why?
|
Molecular Dynamics Simulation | 4 | 2015 | 427 | 0.710 |
Why?
|
Domestic Violence | 1 | 2022 | 180 | 0.700 |
Why?
|
Lymphoid Progenitor Cells | 1 | 2020 | 21 | 0.690 |
Why?
|
Spouses | 1 | 2022 | 286 | 0.660 |
Why?
|
Family Characteristics | 3 | 2021 | 1003 | 0.650 |
Why?
|
Family Planning Services | 2 | 2012 | 279 | 0.640 |
Why?
|
Gap Junctions | 1 | 2020 | 230 | 0.610 |
Why?
|
Rural Population | 6 | 2024 | 2318 | 0.580 |
Why?
|
Leishmaniasis, Visceral | 3 | 2024 | 100 | 0.560 |
Why?
|
Stem Cell Niche | 1 | 2020 | 348 | 0.530 |
Why?
|
Tetanus Toxoid | 2 | 2013 | 189 | 0.500 |
Why?
|
Adolescent Development | 1 | 2019 | 283 | 0.500 |
Why?
|
Miconazole | 1 | 2014 | 9 | 0.470 |
Why?
|
Vinyl Compounds | 1 | 2014 | 22 | 0.470 |
Why?
|
Socioeconomic Factors | 6 | 2016 | 7861 | 0.450 |
Why?
|
Nanotechnology | 2 | 2010 | 714 | 0.440 |
Why?
|
Pregnancy, Unwanted | 1 | 2013 | 24 | 0.430 |
Why?
|
Population Control | 1 | 2012 | 23 | 0.420 |
Why?
|
Nucleic Acid Conformation | 4 | 2021 | 900 | 0.420 |
Why?
|
Tetanus | 1 | 2012 | 52 | 0.410 |
Why?
|
Body Height | 1 | 2019 | 1568 | 0.410 |
Why?
|
Peptides | 2 | 2023 | 4353 | 0.400 |
Why?
|
Malnutrition | 1 | 2019 | 631 | 0.400 |
Why?
|
Pregnancy, Unplanned | 1 | 2013 | 86 | 0.400 |
Why?
|
Pyrrolidines | 1 | 2014 | 340 | 0.400 |
Why?
|
Protein Denaturation | 2 | 2009 | 242 | 0.400 |
Why?
|
Health Surveys | 6 | 2022 | 4056 | 0.390 |
Why?
|
Growth Disorders | 1 | 2017 | 635 | 0.390 |
Why?
|
Nutritional Status | 2 | 2019 | 1627 | 0.370 |
Why?
|
Maternal Health Services | 2 | 2013 | 471 | 0.350 |
Why?
|
Maternal Behavior | 1 | 2012 | 309 | 0.350 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2020 | 2846 | 0.340 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2010 | 91 | 0.340 |
Why?
|
Polymers | 3 | 2024 | 1630 | 0.330 |
Why?
|
Trabeculectomy | 2 | 2021 | 174 | 0.330 |
Why?
|
Muscle Neoplasms | 1 | 2010 | 130 | 0.320 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2010 | 706 | 0.320 |
Why?
|
Birth Weight | 1 | 2017 | 2114 | 0.310 |
Why?
|
Weight Gain | 1 | 2019 | 2356 | 0.310 |
Why?
|
Boron | 1 | 2008 | 37 | 0.310 |
Why?
|
Models, Chemical | 2 | 2021 | 611 | 0.300 |
Why?
|
Parturition | 1 | 2011 | 453 | 0.290 |
Why?
|
Child Health Services | 1 | 2013 | 645 | 0.290 |
Why?
|
Hematopoietic Stem Cells | 1 | 2020 | 3407 | 0.280 |
Why?
|
Metals | 1 | 2011 | 713 | 0.270 |
Why?
|
Infant, Newborn | 9 | 2024 | 26411 | 0.270 |
Why?
|
Emotions | 1 | 2018 | 2768 | 0.270 |
Why?
|
DNA | 3 | 2024 | 7211 | 0.260 |
Why?
|
Receptors, Progesterone | 1 | 2011 | 1145 | 0.260 |
Why?
|
Models, Molecular | 4 | 2009 | 5404 | 0.250 |
Why?
|
Catalysis | 2 | 2023 | 768 | 0.240 |
Why?
|
beta-Cyclodextrins | 1 | 2024 | 67 | 0.230 |
Why?
|
Public Health | 2 | 2021 | 2682 | 0.230 |
Why?
|
Counseling | 1 | 2012 | 1553 | 0.230 |
Why?
|
Logistic Models | 6 | 2017 | 13323 | 0.230 |
Why?
|
Pregnancy | 10 | 2024 | 30200 | 0.230 |
Why?
|
Nanoparticles | 4 | 2020 | 1987 | 0.230 |
Why?
|
Emulsions | 1 | 2024 | 152 | 0.230 |
Why?
|
Plant Leaves | 1 | 2024 | 153 | 0.220 |
Why?
|
Protein Folding | 2 | 2007 | 872 | 0.220 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2011 | 1094 | 0.220 |
Why?
|
Nephrostomy, Percutaneous | 1 | 2023 | 79 | 0.210 |
Why?
|
Antibodies, Protozoan | 1 | 2024 | 251 | 0.210 |
Why?
|
Alginates | 1 | 2024 | 250 | 0.210 |
Why?
|
Nanostructures | 1 | 2008 | 553 | 0.210 |
Why?
|
Circular Dichroism | 3 | 2009 | 337 | 0.210 |
Why?
|
Stereoisomerism | 1 | 2023 | 612 | 0.210 |
Why?
|
Solubility | 1 | 2024 | 1085 | 0.210 |
Why?
|
Depression | 4 | 2024 | 8241 | 0.200 |
Why?
|
Receptors, Estrogen | 1 | 2011 | 2247 | 0.200 |
Why?
|
Antiphospholipid Syndrome | 1 | 2023 | 166 | 0.200 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2017 | 4047 | 0.190 |
Why?
|
RNA | 1 | 2011 | 2726 | 0.190 |
Why?
|
Phlebotomus | 1 | 2021 | 12 | 0.180 |
Why?
|
Psychodidae | 1 | 2021 | 27 | 0.180 |
Why?
|
Plant Extracts | 1 | 2024 | 499 | 0.180 |
Why?
|
Humans | 52 | 2024 | 768393 | 0.180 |
Why?
|
Young Adult | 11 | 2024 | 60049 | 0.180 |
Why?
|
Ethiopia | 2 | 2021 | 482 | 0.180 |
Why?
|
Leishmania donovani | 1 | 2021 | 68 | 0.180 |
Why?
|
Female | 32 | 2024 | 397089 | 0.170 |
Why?
|
Nanofibers | 1 | 2020 | 68 | 0.170 |
Why?
|
Cellulose | 1 | 2020 | 118 | 0.170 |
Why?
|
Adolescent | 11 | 2024 | 89184 | 0.160 |
Why?
|
Vaccines, Acellular | 1 | 2019 | 11 | 0.160 |
Why?
|
Leishmaniasis, Cutaneous | 1 | 2021 | 137 | 0.160 |
Why?
|
Parathyroid Hormone | 2 | 2016 | 1804 | 0.160 |
Why?
|
Phacoemulsification | 1 | 2021 | 151 | 0.160 |
Why?
|
Kidney Calculi | 1 | 2023 | 469 | 0.160 |
Why?
|
Surface Properties | 2 | 2020 | 1167 | 0.160 |
Why?
|
Bordetella pertussis | 1 | 2019 | 45 | 0.160 |
Why?
|
Glaucoma, Angle-Closure | 1 | 2021 | 192 | 0.160 |
Why?
|
Metal Nanoparticles | 2 | 2015 | 405 | 0.160 |
Why?
|
DNA, Single-Stranded | 1 | 2021 | 351 | 0.160 |
Why?
|
Infant | 7 | 2024 | 36510 | 0.160 |
Why?
|
Thermodynamics | 3 | 2024 | 591 | 0.160 |
Why?
|
Temperature | 3 | 2014 | 2235 | 0.160 |
Why?
|
Drug Carriers | 2 | 2024 | 710 | 0.160 |
Why?
|
Child Welfare | 2 | 2013 | 523 | 0.150 |
Why?
|
Sentinel Surveillance | 1 | 2020 | 292 | 0.150 |
Why?
|
Technology, Pharmaceutical | 1 | 2018 | 84 | 0.150 |
Why?
|
Vietnam | 1 | 2019 | 416 | 0.150 |
Why?
|
Base Sequence | 4 | 2024 | 12422 | 0.150 |
Why?
|
Protein Structure, Tertiary | 4 | 2020 | 3779 | 0.150 |
Why?
|
Amyloid | 1 | 2022 | 854 | 0.140 |
Why?
|
Calorimetry, Differential Scanning | 2 | 2009 | 98 | 0.140 |
Why?
|
Directly Observed Therapy | 1 | 2017 | 139 | 0.140 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2024 | 3813 | 0.140 |
Why?
|
Mouth Neoplasms | 1 | 2022 | 597 | 0.140 |
Why?
|
Head and Neck Neoplasms | 2 | 2022 | 2923 | 0.130 |
Why?
|
Fertility | 1 | 2021 | 772 | 0.130 |
Why?
|
Bone Morphogenetic Protein 4 | 1 | 2016 | 163 | 0.130 |
Why?
|
Streptococcal Infections | 1 | 2020 | 619 | 0.130 |
Why?
|
Nanomedicine | 1 | 2018 | 292 | 0.130 |
Why?
|
Peru | 1 | 2019 | 890 | 0.130 |
Why?
|
Health Transition | 1 | 2015 | 35 | 0.130 |
Why?
|
Child Nutrition Disorders | 1 | 2017 | 140 | 0.120 |
Why?
|
Menopause, Premature | 1 | 2016 | 124 | 0.120 |
Why?
|
Adult | 16 | 2024 | 223640 | 0.120 |
Why?
|
Muscle, Skeletal | 1 | 2010 | 4981 | 0.120 |
Why?
|
Ovariectomy | 1 | 2017 | 615 | 0.120 |
Why?
|
Women's Health | 2 | 2016 | 2078 | 0.120 |
Why?
|
Reactive Oxygen Species | 2 | 2020 | 2146 | 0.120 |
Why?
|
Glaucoma, Open-Angle | 1 | 2021 | 742 | 0.120 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2016 | 344 | 0.120 |
Why?
|
Protein Binding | 4 | 2009 | 9343 | 0.120 |
Why?
|
Alendronate | 1 | 2015 | 174 | 0.120 |
Why?
|
Middle Aged | 15 | 2024 | 223491 | 0.120 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2024 | 3781 | 0.110 |
Why?
|
Cations | 2 | 2012 | 240 | 0.110 |
Why?
|
Laser Therapy | 1 | 2021 | 1105 | 0.110 |
Why?
|
Male | 21 | 2024 | 364902 | 0.110 |
Why?
|
Tablets | 1 | 2014 | 149 | 0.110 |
Why?
|
Gold | 3 | 2015 | 488 | 0.110 |
Why?
|
Iron Compounds | 1 | 2013 | 28 | 0.110 |
Why?
|
Polysaccharides | 1 | 2020 | 1024 | 0.110 |
Why?
|
Drugs, Investigational | 1 | 2015 | 213 | 0.110 |
Why?
|
Bacteria | 1 | 2024 | 2221 | 0.110 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2014 | 275 | 0.110 |
Why?
|
Humidity | 1 | 2014 | 206 | 0.110 |
Why?
|
Phagocytosis | 1 | 2019 | 1530 | 0.110 |
Why?
|
Health Personnel | 3 | 2023 | 3380 | 0.110 |
Why?
|
Nucleic Acids | 1 | 2015 | 189 | 0.100 |
Why?
|
Bone Remodeling | 1 | 2016 | 583 | 0.100 |
Why?
|
Perinatal Mortality | 1 | 2013 | 102 | 0.100 |
Why?
|
Primary Health Care | 3 | 2024 | 4748 | 0.100 |
Why?
|
Isoxazoles | 1 | 2014 | 233 | 0.100 |
Why?
|
Sarcopenia | 1 | 2017 | 376 | 0.100 |
Why?
|
Child, Preschool | 6 | 2024 | 42650 | 0.100 |
Why?
|
Maternal Welfare | 1 | 2012 | 113 | 0.100 |
Why?
|
Hospitals, Private | 1 | 2012 | 67 | 0.100 |
Why?
|
Birth Order | 1 | 2012 | 95 | 0.100 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2023 | 1248 | 0.100 |
Why?
|
Amino Acid Sequence | 3 | 2009 | 13423 | 0.100 |
Why?
|
Bone Diseases, Metabolic | 1 | 2015 | 411 | 0.100 |
Why?
|
Home Childbirth | 1 | 2012 | 55 | 0.100 |
Why?
|
Pregnancy, High-Risk | 1 | 2012 | 121 | 0.100 |
Why?
|
Case-Control Studies | 2 | 2024 | 22296 | 0.100 |
Why?
|
Adiponectin | 1 | 2017 | 1117 | 0.090 |
Why?
|
Cultural Characteristics | 1 | 2012 | 250 | 0.090 |
Why?
|
Base Pairing | 1 | 2011 | 139 | 0.090 |
Why?
|
Lung Neoplasms | 2 | 2019 | 13576 | 0.090 |
Why?
|
Poly T | 1 | 2010 | 6 | 0.090 |
Why?
|
Quartz Crystal Microbalance Techniques | 1 | 2010 | 9 | 0.090 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2023 | 2170 | 0.090 |
Why?
|
Peptide Fragments | 1 | 2023 | 5151 | 0.090 |
Why?
|
Refractometry | 1 | 2011 | 57 | 0.090 |
Why?
|
Surgical Flaps | 1 | 2020 | 1682 | 0.090 |
Why?
|
Public Health Practice | 1 | 2013 | 221 | 0.090 |
Why?
|
Molecular Sequence Data | 3 | 2009 | 17626 | 0.090 |
Why?
|
Pressure | 1 | 2014 | 1172 | 0.090 |
Why?
|
Hospitals, Public | 1 | 2012 | 205 | 0.090 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3231 | 0.090 |
Why?
|
Rats | 4 | 2009 | 23835 | 0.090 |
Why?
|
Hematopoiesis | 1 | 2020 | 2058 | 0.090 |
Why?
|
Biphenyl Compounds | 1 | 2015 | 1026 | 0.090 |
Why?
|
Particle Size | 2 | 2020 | 1653 | 0.090 |
Why?
|
Solvents | 1 | 2011 | 298 | 0.090 |
Why?
|
Odds Ratio | 2 | 2013 | 9682 | 0.090 |
Why?
|
Software | 1 | 2024 | 4453 | 0.080 |
Why?
|
Thrombosis | 1 | 2023 | 2955 | 0.080 |
Why?
|
Geography | 1 | 2011 | 654 | 0.080 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 861 | 0.080 |
Why?
|
Mitochondria | 2 | 2020 | 3675 | 0.080 |
Why?
|
Maternal Age | 1 | 2012 | 809 | 0.080 |
Why?
|
Mesenchymal Stem Cells | 1 | 2020 | 1671 | 0.080 |
Why?
|
Nucleic Acid Hybridization | 1 | 2010 | 1305 | 0.080 |
Why?
|
Body Temperature | 1 | 2012 | 781 | 0.080 |
Why?
|
Animals | 12 | 2021 | 169337 | 0.080 |
Why?
|
Metabolic Diseases | 1 | 2015 | 684 | 0.080 |
Why?
|
Estrogens | 1 | 2015 | 1534 | 0.080 |
Why?
|
Pandemics | 4 | 2022 | 8753 | 0.080 |
Why?
|
Prospective Studies | 7 | 2023 | 54920 | 0.080 |
Why?
|
Life Expectancy | 1 | 2015 | 1249 | 0.080 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2020 | 2185 | 0.080 |
Why?
|
Menopause | 1 | 2016 | 1653 | 0.080 |
Why?
|
Premature Birth | 1 | 2020 | 1814 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2020 | 5336 | 0.070 |
Why?
|
Body Composition | 1 | 2017 | 2461 | 0.070 |
Why?
|
Occupational Diseases | 1 | 2015 | 1490 | 0.070 |
Why?
|
Actomyosin | 1 | 2007 | 114 | 0.070 |
Why?
|
Communicable Diseases | 1 | 2015 | 873 | 0.070 |
Why?
|
Age Distribution | 1 | 2012 | 2877 | 0.070 |
Why?
|
Molecular Conformation | 1 | 2008 | 540 | 0.070 |
Why?
|
Lasers | 1 | 2011 | 952 | 0.070 |
Why?
|
Parenting | 1 | 2012 | 708 | 0.070 |
Why?
|
Folic Acid | 1 | 2013 | 1336 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2022 | 4069 | 0.070 |
Why?
|
Neutrophils | 1 | 2019 | 3785 | 0.070 |
Why?
|
Neoplasm Staging | 3 | 2022 | 11254 | 0.060 |
Why?
|
Lymph Nodes | 2 | 2022 | 3471 | 0.060 |
Why?
|
Macromolecular Substances | 1 | 2008 | 1435 | 0.060 |
Why?
|
Homeostasis | 1 | 2016 | 3349 | 0.060 |
Why?
|
Histones | 1 | 2015 | 2592 | 0.060 |
Why?
|
Intraocular Pressure | 2 | 2021 | 1304 | 0.060 |
Why?
|
Research Design | 1 | 2021 | 6210 | 0.060 |
Why?
|
DNA Primers | 1 | 2009 | 2825 | 0.060 |
Why?
|
Cell Differentiation | 2 | 2020 | 11668 | 0.060 |
Why?
|
Delivery, Obstetric | 1 | 2012 | 952 | 0.060 |
Why?
|
Agglutination Tests | 1 | 2024 | 43 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11854 | 0.060 |
Why?
|
Tuberculosis | 1 | 2017 | 2029 | 0.060 |
Why?
|
Methacrylates | 1 | 2024 | 110 | 0.060 |
Why?
|
Environmental Monitoring | 1 | 2011 | 1463 | 0.060 |
Why?
|
Antibodies, Anticardiolipin | 1 | 2023 | 62 | 0.060 |
Why?
|
Lupus Coagulation Inhibitor | 1 | 2023 | 32 | 0.060 |
Why?
|
Polyvinyls | 1 | 2024 | 156 | 0.060 |
Why?
|
Prevalence | 2 | 2020 | 15872 | 0.060 |
Why?
|
Antibodies, Antiphospholipid | 1 | 2023 | 72 | 0.060 |
Why?
|
Models, Biological | 1 | 2020 | 9493 | 0.050 |
Why?
|
Algorithms | 1 | 2024 | 14154 | 0.050 |
Why?
|
Drug Compounding | 1 | 2024 | 243 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2017 | 3922 | 0.050 |
Why?
|
Breast Neoplasms | 1 | 2011 | 21162 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3118 | 0.050 |
Why?
|
Lymphatic Metastasis | 1 | 2011 | 2925 | 0.050 |
Why?
|
Telemedicine | 1 | 2020 | 3107 | 0.050 |
Why?
|
Seroepidemiologic Studies | 1 | 2024 | 405 | 0.050 |
Why?
|
Protein Structure, Secondary | 1 | 2006 | 1216 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3241 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 2015 | 2514 | 0.050 |
Why?
|
Suction | 1 | 2023 | 268 | 0.050 |
Why?
|
Computer Simulation | 2 | 2008 | 6277 | 0.050 |
Why?
|
Coenzymes | 1 | 2022 | 101 | 0.050 |
Why?
|
Capacity Building | 1 | 2024 | 265 | 0.050 |
Why?
|
Antigens, Protozoan | 1 | 2024 | 315 | 0.050 |
Why?
|
Patient Education as Topic | 1 | 2012 | 2337 | 0.050 |
Why?
|
Amyloidogenic Proteins | 1 | 2022 | 154 | 0.050 |
Why?
|
Child | 5 | 2024 | 80891 | 0.050 |
Why?
|
Psychometrics | 1 | 2011 | 3069 | 0.050 |
Why?
|
Fungi | 1 | 2024 | 345 | 0.050 |
Why?
|
Postmenopause | 1 | 2011 | 2518 | 0.050 |
Why?
|
Mutation | 4 | 2020 | 30228 | 0.050 |
Why?
|
Residence Characteristics | 1 | 2011 | 2122 | 0.050 |
Why?
|
Xenodiagnosis | 1 | 2021 | 1 | 0.050 |
Why?
|
Fluorescent Dyes | 1 | 2009 | 1926 | 0.050 |
Why?
|
Amino Acid Motifs | 1 | 2003 | 929 | 0.050 |
Why?
|
Osteoblasts | 2 | 2017 | 1154 | 0.050 |
Why?
|
Alanine | 1 | 2003 | 613 | 0.050 |
Why?
|
Trabecular Meshwork | 1 | 2021 | 101 | 0.050 |
Why?
|
Scattering, Small Angle | 1 | 2021 | 61 | 0.050 |
Why?
|
Rural Health Services | 1 | 2024 | 393 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 5422 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2017 | 14784 | 0.040 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2003 | 1682 | 0.040 |
Why?
|
Dietary Supplements | 1 | 2013 | 3443 | 0.040 |
Why?
|
Chronic Disease | 1 | 2015 | 9379 | 0.040 |
Why?
|
Environmental Exposure | 1 | 2015 | 4528 | 0.040 |
Why?
|
Systems Analysis | 1 | 2021 | 168 | 0.040 |
Why?
|
X-Ray Diffraction | 1 | 2021 | 417 | 0.040 |
Why?
|
Asthenia | 1 | 2019 | 16 | 0.040 |
Why?
|
Time Factors | 2 | 2012 | 40272 | 0.040 |
Why?
|
Asymptomatic Infections | 1 | 2021 | 135 | 0.040 |
Why?
|
Signal Transduction | 3 | 2019 | 23631 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12092 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 14737 | 0.040 |
Why?
|
Pertussis Vaccine | 1 | 2019 | 39 | 0.040 |
Why?
|
Platinum Compounds | 1 | 2019 | 95 | 0.040 |
Why?
|
Mice, Inbred BALB C | 2 | 2019 | 6234 | 0.040 |
Why?
|
Complement Factor H | 1 | 2019 | 110 | 0.040 |
Why?
|
Age Factors | 2 | 2016 | 18471 | 0.040 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 326 | 0.040 |
Why?
|
Particulate Matter | 1 | 2011 | 2609 | 0.040 |
Why?
|
Patient Simulation | 1 | 2021 | 297 | 0.040 |
Why?
|
Polyethylene Glycols | 1 | 2024 | 1195 | 0.040 |
Why?
|
Streptococcus agalactiae | 1 | 2020 | 338 | 0.040 |
Why?
|
Stroke | 1 | 2021 | 9742 | 0.040 |
Why?
|
Occupations | 1 | 2021 | 519 | 0.040 |
Why?
|
Siblings | 1 | 2023 | 829 | 0.040 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2021 | 414 | 0.040 |
Why?
|
Whooping Cough | 1 | 2019 | 86 | 0.040 |
Why?
|
Quarantine | 1 | 2020 | 187 | 0.040 |
Why?
|
Cohort Studies | 2 | 2021 | 41795 | 0.040 |
Why?
|
Water | 1 | 2024 | 1418 | 0.040 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2021 | 508 | 0.040 |
Why?
|
Treatment Outcome | 5 | 2023 | 65379 | 0.040 |
Why?
|
Policy | 1 | 2022 | 514 | 0.040 |
Why?
|
Microbial Sensitivity Tests | 1 | 2024 | 1961 | 0.040 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2019 | 826 | 0.040 |
Why?
|
Retrospective Studies | 5 | 2022 | 81801 | 0.040 |
Why?
|
Vaccination | 2 | 2021 | 3431 | 0.040 |
Why?
|
Decision Making | 1 | 2011 | 3953 | 0.040 |
Why?
|
Healthcare Disparities | 1 | 2013 | 3413 | 0.040 |
Why?
|
Pilot Projects | 2 | 2021 | 8731 | 0.040 |
Why?
|
Adenylate Kinase | 1 | 2017 | 102 | 0.030 |
Why?
|
Anti-Infective Agents | 1 | 2024 | 985 | 0.030 |
Why?
|
Lumbar Vertebrae | 2 | 2017 | 1885 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13697 | 0.030 |
Why?
|
Cell Respiration | 1 | 2017 | 201 | 0.030 |
Why?
|
Genome, Viral | 1 | 2020 | 673 | 0.030 |
Why?
|
Peritonitis | 1 | 2019 | 368 | 0.030 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2024 | 954 | 0.030 |
Why?
|
Prognosis | 2 | 2022 | 30022 | 0.030 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2019 | 631 | 0.030 |
Why?
|
Diaphyses | 1 | 2015 | 65 | 0.030 |
Why?
|
Sanitation | 1 | 2015 | 83 | 0.030 |
Why?
|
Oxidative Phosphorylation | 1 | 2017 | 501 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2013 | 5375 | 0.030 |
Why?
|
Calcification, Physiologic | 1 | 2015 | 171 | 0.030 |
Why?
|
Autoantigens | 1 | 2019 | 891 | 0.030 |
Why?
|
Vagina | 1 | 2020 | 845 | 0.030 |
Why?
|
Crystallization | 1 | 2015 | 521 | 0.030 |
Why?
|
Calcium | 1 | 2007 | 5794 | 0.030 |
Why?
|
HIV Infections | 1 | 2021 | 17575 | 0.030 |
Why?
|
Phosphoinositide Phospholipase C | 1 | 2014 | 29 | 0.030 |
Why?
|
Haplotypes | 1 | 2020 | 2724 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 2017 | 1183 | 0.030 |
Why?
|
Biofilms | 1 | 2019 | 634 | 0.030 |
Why?
|
Anabolic Agents | 1 | 2016 | 256 | 0.030 |
Why?
|
Heterotrimeric GTP-Binding Proteins | 1 | 2014 | 94 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 2019 | 998 | 0.030 |
Why?
|
Mutation, Missense | 1 | 2023 | 2593 | 0.030 |
Why?
|
Bone Resorption | 1 | 2017 | 727 | 0.030 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2023 | 6034 | 0.030 |
Why?
|
Antigens | 1 | 2019 | 1443 | 0.030 |
Why?
|
Parity | 1 | 2016 | 938 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2014 | 466 | 0.030 |
Why?
|
Mental Health Services | 1 | 2024 | 1731 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2014 | 378 | 0.030 |
Why?
|
Calcineurin | 1 | 2014 | 236 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2024 | 4775 | 0.030 |
Why?
|
Phylogeny | 1 | 2020 | 2843 | 0.030 |
Why?
|
Antibodies, Bacterial | 1 | 2019 | 1478 | 0.030 |
Why?
|
Interleukin-17 | 1 | 2019 | 923 | 0.030 |
Why?
|
Spleen | 1 | 2019 | 2296 | 0.030 |
Why?
|
Risk Factors | 2 | 2017 | 74962 | 0.030 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2014 | 432 | 0.030 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 2012 | 199 | 0.030 |
Why?
|
Nucleic Acid Denaturation | 1 | 2012 | 110 | 0.020 |
Why?
|
Luciferases | 1 | 2014 | 712 | 0.020 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2017 | 848 | 0.020 |
Why?
|
Thrombolytic Therapy | 1 | 2021 | 2050 | 0.020 |
Why?
|
Computational Biology | 1 | 2024 | 3543 | 0.020 |
Why?
|
Random Allocation | 1 | 2016 | 2397 | 0.020 |
Why?
|
NFATC Transcription Factors | 1 | 2014 | 393 | 0.020 |
Why?
|
Internet | 1 | 2024 | 3107 | 0.020 |
Why?
|
Osteoclasts | 1 | 2015 | 712 | 0.020 |
Why?
|
Genetic Markers | 1 | 2017 | 2604 | 0.020 |
Why?
|
Visual Acuity | 1 | 2021 | 2714 | 0.020 |
Why?
|
Hospitalization | 2 | 2021 | 10844 | 0.020 |
Why?
|
Autoantibodies | 1 | 2019 | 2126 | 0.020 |
Why?
|
Osteogenesis | 1 | 2017 | 1295 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2019 | 3164 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2019 | 2460 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2020 | 4250 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2014 | 1524 | 0.020 |
Why?
|
Anemia | 1 | 2019 | 1519 | 0.020 |
Why?
|
Cyclic AMP | 1 | 2014 | 1468 | 0.020 |
Why?
|
Calcium Signaling | 1 | 2014 | 739 | 0.020 |
Why?
|
Quality Improvement | 1 | 2024 | 3858 | 0.020 |
Why?
|
Rabbits | 1 | 2015 | 4781 | 0.020 |
Why?
|
Femur | 1 | 2015 | 1311 | 0.020 |
Why?
|
Mental Health | 1 | 2023 | 3276 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2015 | 1735 | 0.020 |
Why?
|
Hospitals | 1 | 2022 | 3906 | 0.020 |
Why?
|
Up-Regulation | 1 | 2017 | 4142 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 26375 | 0.020 |
Why?
|
Tomography, Optical Coherence | 1 | 2021 | 2957 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2014 | 1748 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2019 | 1889 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2019 | 4570 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2010 | 20765 | 0.020 |
Why?
|
Mice | 3 | 2019 | 82017 | 0.020 |
Why?
|
Survival Analysis | 1 | 2019 | 10117 | 0.020 |
Why?
|
Escherichia coli | 1 | 2019 | 4211 | 0.020 |
Why?
|
Aged | 3 | 2019 | 171562 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 4209 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2017 | 8199 | 0.020 |
Why?
|
Osteoporosis | 1 | 2015 | 1606 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2013 | 2437 | 0.020 |
Why?
|
Occupational Exposure | 1 | 2015 | 1817 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2014 | 4291 | 0.010 |
Why?
|
Cell Survival | 1 | 2014 | 5792 | 0.010 |
Why?
|
Health Behavior | 1 | 2015 | 2647 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10377 | 0.010 |
Why?
|
Databases, Factual | 1 | 2019 | 8075 | 0.010 |
Why?
|
Equipment Design | 1 | 2011 | 3529 | 0.010 |
Why?
|
Bone Density | 1 | 2015 | 3559 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9433 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2016 | 14481 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18362 | 0.010 |
Why?
|
Risk Assessment | 1 | 2015 | 24318 | 0.010 |
Why?
|